dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Sotsiaalministeerium
Sissetulev kiriAvalik

Pöördumine

Sotsiaalministeerium · 6. november 2020
Viit
1.4-2/3189-1
Registreeritud
6. november 2020
Dokumendi liik
Sissetulev kiri
Adressaat
Puritech
Saabumis/saatmisviis
e-post
Funktsioon
1.4 EL otsustusprotsess ja rahvusvaheline koostöö
Sari
1.4-2 Rahvusvahelise koostöö korraldamisega seotud kirjavahetus (Arhiiviväärtuslik)
Toimik
1.4-2/2020
Vastutaja
Agris Koppel (Sotsiaalministeerium, Kantsleri vastutusvaldkond, Terviseala asekantsleri vastutusvaldkond, Tervisesüsteemi arendamise osakond)
Lahendamise tähtaeg
6. detsember 2020

Failid

  • 📎E-kiri.pdf99 KB

Sisu (failidest)

Saatja: Young Hun Ji <[email protected]> Saadetud: 05.11.2020 16:42 Adressaat: Tanel Kiik <[email protected]> Koopia: SM Info <[email protected]> Teema: Introducing our novel thermochromic medical device designed to combat COVID-19 Dear Mr. Tanel Kiik, &nbsp; My name is Young Hun Ji, and I am the EU Managing Director of Puritech, a tech company based in South Korea. I am writing to introduce to you our medical device, the PuriBAND, which is a thermochromic plaster that immediately detects and visually indicates changes in the wearers body temperature. I am reaching out to you specifically, as I am confident that PuriBAND usage could dramatically enhance Estonias COVID-19 management and prevention efficacy. &nbsp; The PuriBAND functions as follows: It is essentially a small round sticker, applied to the skins surface (e.g., on the back of ones hand or wrist), which then turns color in response to significant changes in body temperature. Between the normal temperature range of 35°C and below 37.5°C, the PuriBAND will show a color between brown and green. At temperatures approaching 37.5°C and above, however, the PuriBAND will turn yellow. Hence, it can be used to visually alert users of a feverthe most common symptom of COVID-19. &nbsp; The PuriBAND is an excellent first-line defense against COVID-19 for two reasons. First, the PuriBAND is highly versatile and resource-efficient. It enables constant temperature monitoring of a large number of individuals with minimal effort and virtually zero disruptions during work or other daily activities. It is thus effective in any setting where adequate social distancing measures and frequent body temperature checks are not easily implementable. This includes hospitals and care homes, which accommodate the elderly and other risk group members; schools, kindergartens, and daycare centers, where large groups of young children congregate; and airports, where travelers and essential workers with a fever need to be quickly identified and set aside for further medical examination. In all of these settings, the PuriBAND makes body temperature monitoring of large groups of people practically viable and time- and cost-efficient. &nbsp; Second, the PuriBAND has extremely high thermochromic precision and responsiveness. In thermochromic materials, sensitivity to temperature change is determined by the size of the microcapsules containing the thermochromic dye. At Puritech, we utilize state-of-the-science technology to manufacture extremely fine thermochromic microcapsules with a diameter between 1 and 6 micrometers. This makes the PuriBAND more sensitive to temperature changes compared to other, similar products using thermochromic materials. &nbsp; Against the backdrop of the COVID-19 outbreak, PuriBAND demand and usage has surged in South Korea and other countries such as Japan and the U.S., and this has prompted us to begin mass production. This year, we obtained certifications of FDA registration and CE marking for the PuriBAND. Additionally, we obtained certifications for ISO 13485 (which tests compliance with requirements regarding the design and manufacture of medical devices) and ISO 10993 (which involves a series of tests evaluating biocompatibility of medical devices to minimize biological risk). &nbsp; I would like to urge you to consider incorporating the PuriBAND into Estonias multi-faceted strategy to eradicate COVID-19. I am confident that PuriBAND usage would help protect the lives of Estonias residents, and, furthermore, enable Estonian organizational bodies to better optimize other COVID-19 management efforts and resource allocations. &nbsp; Please let me know if you have any questions or wish to know more about the PuriBAND or Puritech. I will be happy to provide further information. You may also visit our website at . Thank you so much for your time. &nbsp; Kind regards, Young Hun Ji &nbsp; Young Hun Ji, Ph.D. EU Managing Director Puritech &nbsp; Sent from for Windows 10 &nbsp;
Allikas: Sotsiaalministeerium dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel